08622.HK
Huakang Biomedical Holdings Company Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK
HKD 0.19
+8.99%Margins
Gross margin
61.3%
EBITDA margin
-16.1%
EBIT margin
-25.0%
Net margin
-15.6%
FCF margin
-22.2%
-10.3%
Return on equity
-7.6%
Return on assets
-14.3%
Return on invested capital
0.49x
Asset turnover
-HKD 7.1M
Cash from operations
HKD 0.09
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026